content of news

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Prev Message Back To Forum Threaded View Next Message

bankerson

Rank: Treasurer [?]

Points: 22820 [?]

Votes: 138 Score: 2.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

content of news

posted on Nov 10, 2008 05:14AM

Pluristem Therapeutics Inc. to Present its Clinical Plan at the Rodman & Renshaw 10th Annual Healthcare Conference
Monday November 10, 4:00 am ET

NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics Company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, announced today that William R. Prather RPh, MD, Pluristem’s Sr. VP of Corporate Development, will present at the Rodman & Renshaw 10th Annual Healthcare Conference at 2:25PM on Monday, November 10th, 2008 at the New York Palace Hotel, New York, NY.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply